摘要
目的:评价甘精胰岛素联合瑞格列奈治疗2-型糖尿病的疗效及安全性。方法:收集我院2009年5月-2009年11月间诊治的2-型糖尿病患者38例,观察应用甘精胰岛素联合瑞格列奈治疗前后空腹血糖(FBG)、餐后2h血糖(P2hBG)、糖化血红蛋白(HbA1C)情况。结果:3个月后患者空腹血糖、餐后2h血糖及HbA1C较治疗前显著下降(P<0.01)。结论:甘精胰岛素联合瑞格列奈治疗2-型糖尿病血糖控制效果好,低血糖发生率低。
Objective：Evaluation the treatment of efficacy and safety of insulin glargine combined repaglinide of type 2 diabetes.Methods：Collected in our hospital from May 2009 to November 2009 out of 38 cases with type 2 diabetes mellitus.Application of insulin glargine combined Repaglinide treatment. Observing the fasting blood glucose,2-hour postprandial blood glucose,glycolated hemoglobin changes.Results：3 months after treatment in patients with fasting blood glucose and 2-hour postprandial blood glucose glyeated hemoglobin decreased significantly （P〈0.01）.Conclusions：the treatment of insulin glargine combined repaglinide of type 2 diabetes is better at blood glucose control effect,lower blood sugar incidence.
出处
《医学信息（中旬刊）》
2010年第4期737-738,共2页
Medical Information Operations Sciences Fascicule
